Literature DB >> 36083576

Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential.

Kimberly W Y Mak1, Aws F Mustafa1, Denise D Belsham2,3,4.   

Abstract

The brain orchestrates whole-body metabolism through an intricate system involving interneuronal crosstalk and communication. Specifically, a key player in this complex circuitry is the hypothalamus that controls feeding behaviour, energy expenditure, body weight and metabolism, whereby hypothalamic neurons sense and respond to circulating hormones, nutrients, and chemicals. Dysregulation of these neurons contributes to the development of metabolic disorders, such as obesity and type 2 diabetes. The involvement of hypothalamic microRNAs, post-transcriptional regulators of gene expression, in the central regulation of energy homeostasis has become increasingly apparent, although not completely delineated. This review summarizes current evidence demonstrating the regulation of feeding-related neuropeptides by brain-derived microRNAs as well as the regulation of specific miRNAs by nutrients and other peripheral signals. Moreover, the involvement of microRNAs in the central nervous system control of insulin, leptin, and estrogen signal transduction is examined. Finally, the therapeutic and diagnostic potential of microRNAs for metabolic disorders will be discussed and the regulation of brain-derived microRNAs by nutrients and other peripheral signals is considered. Demonstrating a critical role of microRNAs in hypothalamic regulation of energy homeostasis is an innovative route to uncover novel biomarkers and therapeutic candidates for metabolic disorders.
© 2022. The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences.

Entities:  

Keywords:  Energy homeostasis; Estrogen; Hypothalamus; Insulin; Leptin; Neuropeptide; microRNAs

Mesh:

Substances:

Year:  2022        PMID: 36083576     DOI: 10.1007/s43440-022-00409-5

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.919


  164 in total

Review 1.  The impact of obesity on psychological well-being.

Authors:  Jane Wardle; Lucy Cooke
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-09       Impact factor: 4.690

Review 2.  Diets and drugs for weight loss and health in obesity - An update.

Authors:  Jan Aaseth; Stian Ellefsen; Urban Alehagen; Tine M Sundfør; Jan Alexander
Journal:  Biomed Pharmacother       Date:  2021-05-31       Impact factor: 6.529

Review 3.  Effects of endocrine disruptors on obesity.

Authors:  Retha R Newbold; Elizabeth Padilla-Banks; Wendy N Jefferson; Jerrold J Heindel
Journal:  Int J Androl       Date:  2008-04

Review 4.  Adverse Effects of GLP-1 Receptor Agonists.

Authors:  Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal:  Rev Diabet Stud       Date:  2015-02-10

5.  Obesity : impact on cardiovascular disease

Authors: 
Journal:  Circulation       Date:  1998-10-06       Impact factor: 29.690

Review 6.  Pathways to obesity.

Authors:  E Jéquier
Journal:  Int J Obes Relat Metab Disord       Date:  2002-09

7.  Organizational effects of perinatal exposure to bisphenol-A and diethylstilbestrol on arcuate nucleus circuitry controlling food intake and energy expenditure in male and female CD-1 mice.

Authors:  Harry Mackay; Zachary R Patterson; Rim Khazall; Shoyeb Patel; Dina Tsirlin; Alfonso Abizaid
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

Review 8.  Maintenance of Lost Weight and Long-Term Management of Obesity.

Authors:  Kevin D Hall; Scott Kahan
Journal:  Med Clin North Am       Date:  2018-01       Impact factor: 5.456

Review 9.  Mechanism linking diabetes mellitus and obesity.

Authors:  Abdullah S Al-Goblan; Mohammed A Al-Alfi; Muhammad Z Khan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-12-04       Impact factor: 3.168

10.  Possible Obesogenic Effects of Bisphenols Accumulation in the Human Brain.

Authors:  Pantelis Charisiadis; Xanthi D Andrianou; Thomas P van der Meer; Wilfred F A den Dunnen; Dick F Swaab; Bruce H R Wolffenbuttel; Konstantinos C Makris; Jana V van Vliet-Ostaptchouk
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.